Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.
Johnson & Johnson's innovative medicines division shows promise with expected revenues of $57bn by 2025. See more about JNJ ...
Key Takeaways Johnson & Johnson's third-quarter profit fell sharply due to billions in one-time expenses like legal costs.The ...
The Lions have scored touchdowns on trick plays each of the last three weeks, and continued to hammer Dallas even after the ...
House Speaker Mike Johnson is taking his "American Revival" tour to the swing states with less than three weeks until ...
1hon MSN
Republicans won 11 of New York’s 26 House seats two years ago, but their number was reduced by one following the expulsion of ...
The denial was the latest loss for the LeRoy Republican convicted of receiving $110,000 in bribes & trysts with a sex worker ...
Utah Forward candidate Laura Johnson faces off against Republican Rod Hall for the Utah Board of Education District 3 seat.
Paul Johnson is standing down as director of the Institute for Fiscal Studies after more than a decade as one of the most ...
A jury awarded a Somers man $15 million in compensatory damages Tuesday, siding with claims that years of using Johnson & ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback